MARSH & MCLENNAN COMPANIES, INC. Quarterly Liabilities and Equity in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Marsh & Mclennan Companies, Inc. quarterly Liabilities and Equity history and growth rate from Q1 2010 to Q3 2024.
  • Marsh & Mclennan Companies, Inc. Liabilities and Equity for the quarter ending September 30, 2024 was $49.9B, a 3.88% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $49.9B +$1.86B +3.88% Sep 30, 2024 10-Q 2024-10-17
Q2 2024 $48.6B +$2.03B +4.35% Jun 30, 2024 10-Q 2024-07-18
Q1 2024 $47.6B +$13.2B +38.5% Mar 31, 2024 10-Q 2024-04-18
Q4 2023 $48B +$3.92B +8.88% Dec 31, 2023 10-Q 2024-10-17
Q3 2023 $48B +$16B +49.9% Sep 30, 2023 10-Q 2023-10-19
Q2 2023 $46.6B +$13.1B +39.3% Jun 30, 2023 10-Q 2023-07-20
Q1 2023 $34.4B +$670M +1.99% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 $44.1B +$9.73B +28.3% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $32B -$959M -2.91% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 $33.4B +$487M +1.48% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 $33.7B +$1.42B +4.38% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 $34.4B +$1.34B +4.05% Dec 31, 2021 10-K 2023-02-13
Q3 2021 $33B +$301M +0.92% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 $33B +$784M +2.44% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $32.3B +$882M +2.81% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 $33B +$1.69B +5.4% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $32.7B +$1.58B +5.09% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $32.2B +$53M +0.17% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $31.4B +$1.25B +4.16% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $31.4B +$9.78B +45.3% Dec 31, 2019 10-K 2021-02-17
Q3 2019 $31.1B +$9.97B +47.2% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $32.1B +$11B +51.8% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $30.1B +$8.76B +41% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $21.6B +$1.15B +5.62% Dec 31, 2018 10-K 2020-02-20
Q3 2018 $21.1B +$1.44B +7.31% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $21.2B +$1.72B +8.83% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $21.4B +$2.41B +12.7% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $20.4B +$2.24B +12.3% Dec 31, 2017 10-K 2019-02-21
Q3 2017 $19.7B +$1.33B +7.26% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $19.4B +$1.37B +7.56% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $19B +$841M +4.64% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $18.2B -$26M -0.14% Dec 31, 2016 8-K 2018-05-09
Q3 2016 $18.4B +$634M +3.58% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $18.1B +$663M +3.81% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $18.1B +$1.29B +7.69% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 $18.2B +$423M +2.38% Dec 31, 2015 10-K 2017-02-24
Q3 2015 $17.7B -$263M -1.46% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $17.4B -$175M -1% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 $16.8B +$257M +1.55% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $17.8B +$813M +4.79% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $18B +$1.01B +5.96% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $17.6B +$1.75B +11% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $16.6B +$1.04B +6.69% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $17B +$692M +4.25% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $17B +$1.24B +7.88% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $15.8B +$636M +4.18% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $15.5B +$527M +3.51% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $16.3B +$834M +5.4% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $15.7B +$615M +4.07% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $15.2B -$249M -1.61% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $15B -$63M -0.42% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $15.5B +$144M +0.94% Dec 31, 2011 8-K 2013-05-10
Q3 2011 $15.1B +$218M +1.46% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $15.5B -$170M -1.09% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $15.1B +$111M +0.74% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $15.3B Dec 31, 2010 10-K 2012-02-28
Q3 2010 $14.9B Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $15.6B Jun 30, 2010 10-Q/A 2010-08-17
Q1 2010 $15B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.